FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4210328126> ?p ?o ?g. }

• W4210328126 endingPage "215" @default.
• W4210328126 startingPage "215" @default.
• W4210328126 abstract "Multiple sclerosis (MS) patients receiving natalizumab and who are at risk of developing progressive multifocal leukoencephalopathy (PML) often switch to other high-efficacy disease-modifying therapies including fingolimod as a risk mitigation strategy, which could impact treatment safety and effectiveness. The TRANSITION study aimed to evaluate the safety of fingolimod over two years in patients with MS after switching from natalizumab in a real-world setting. The safety and effectiveness were assessed by monitoring serious and other adverse events (SAEs, AEs). We assessed effectiveness by recording relapses, Expanded Disability Status Scale (EDSS) scores, and MRI activity. Of 637 patients enrolled, 505 completed the study (mean age, 42 years). Overall, 72.8% and 12.7% experienced AEs and SAEs respectively. The most common AEs were fatigue, headache, and urinary tract infection; no cases of PML were observed. Fingolimod treatment resulted in low disease activity. Patients with ≤8 weeks washout period had a markedly lower risk of relapses (4.5%) than those with >8 weeks (51.4%). In patients switching from natalizumab to fingolimod, no new safety signals with overall low relapse activity were observed in patients with washout latencies of ≤8 weeks before fingolimod initiation. Fingolimod was found to be safe and effective in patients transitioning from natalizumab." @default.
• W4210328126 created "2022-02-08" @default.
• W4210328126 creator A5000363730 @default.
• W4210328126 creator A5023725739 @default.
• W4210328126 creator A5028230236 @default.
• W4210328126 creator A5042973046 @default.
• W4210328126 creator A5050196672 @default.
• W4210328126 creator A5050790601 @default.
• W4210328126 creator A5067317369 @default.
• W4210328126 creator A5068676018 @default.
• W4210328126 creator A5077635103 @default.
• W4210328126 creator A5086409600 @default.
• W4210328126 creator A5089131482 @default.
• W4210328126 date "2022-02-04" @default.
• W4210328126 modified "2023-09-25" @default.
• W4210328126 title "Safety of Fingolimod in Patients with Multiple Sclerosis Switched from Natalizumab: Results from TRANSITION―A 2-Year, Multicenter, Observational, Cohort Study" @default.
• W4210328126 cites W1986991730 @default.
• W4210328126 cites W1997159649 @default.
• W4210328126 cites W2019582599 @default.
• W4210328126 cites W2023149067 @default.
• W4210328126 cites W2043003871 @default.
• W4210328126 cites W2103758700 @default.
• W4210328126 cites W2104948944 @default.
• W4210328126 cites W2118735809 @default.
• W4210328126 cites W2133392888 @default.
• W4210328126 cites W2149457184 @default.
• W4210328126 cites W2151340435 @default.
• W4210328126 cites W2162469926 @default.
• W4210328126 cites W2168198006 @default.
• W4210328126 cites W2196420394 @default.
• W4210328126 cites W2344473058 @default.
• W4210328126 cites W2538374410 @default.
• W4210328126 cites W2540646744 @default.
• W4210328126 cites W2569954169 @default.
• W4210328126 cites W2610990451 @default.
• W4210328126 cites W2745850917 @default.
• W4210328126 cites W2748840293 @default.
• W4210328126 cites W2756086242 @default.
• W4210328126 cites W2796904335 @default.
• W4210328126 cites W2810227481 @default.
• W4210328126 cites W2876138996 @default.
• W4210328126 cites W2962511891 @default.
• W4210328126 cites W2996150345 @default.
• W4210328126 doi "https://doi.org/10.3390/brainsci12020215" @default.
• W4210328126 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35203978" @default.
• W4210328126 hasPublicationYear "2022" @default.
• W4210328126 type Work @default.
• W4210328126 citedByCount "3" @default.
• W4210328126 countsByYear W42103281262022 @default.
• W4210328126 crossrefType "journal-article" @default.
• W4210328126 hasAuthorship W4210328126A5000363730 @default.
• W4210328126 hasAuthorship W4210328126A5023725739 @default.
• W4210328126 hasAuthorship W4210328126A5028230236 @default.
• W4210328126 hasAuthorship W4210328126A5042973046 @default.
• W4210328126 hasAuthorship W4210328126A5050196672 @default.
• W4210328126 hasAuthorship W4210328126A5050790601 @default.
• W4210328126 hasAuthorship W4210328126A5067317369 @default.
• W4210328126 hasAuthorship W4210328126A5068676018 @default.
• W4210328126 hasAuthorship W4210328126A5077635103 @default.
• W4210328126 hasAuthorship W4210328126A5086409600 @default.
• W4210328126 hasAuthorship W4210328126A5089131482 @default.
• W4210328126 hasBestOaLocation W42103281261 @default.
• W4210328126 hasConcept C126322002 @default.
• W4210328126 hasConcept C1862650 @default.
• W4210328126 hasConcept C187212893 @default.
• W4210328126 hasConcept C197934379 @default.
• W4210328126 hasConcept C203014093 @default.
• W4210328126 hasConcept C2776036978 @default.
• W4210328126 hasConcept C2780640218 @default.
• W4210328126 hasConcept C2780644213 @default.
• W4210328126 hasConcept C2780892749 @default.
• W4210328126 hasConcept C2781004633 @default.
• W4210328126 hasConcept C71924100 @default.
• W4210328126 hasConcept C72563966 @default.
• W4210328126 hasConceptScore W4210328126C126322002 @default.
• W4210328126 hasConceptScore W4210328126C1862650 @default.
• W4210328126 hasConceptScore W4210328126C187212893 @default.
• W4210328126 hasConceptScore W4210328126C197934379 @default.
• W4210328126 hasConceptScore W4210328126C203014093 @default.
• W4210328126 hasConceptScore W4210328126C2776036978 @default.
• W4210328126 hasConceptScore W4210328126C2780640218 @default.
• W4210328126 hasConceptScore W4210328126C2780644213 @default.
• W4210328126 hasConceptScore W4210328126C2780892749 @default.
• W4210328126 hasConceptScore W4210328126C2781004633 @default.
• W4210328126 hasConceptScore W4210328126C71924100 @default.
• W4210328126 hasConceptScore W4210328126C72563966 @default.
• W4210328126 hasIssue "2" @default.
• W4210328126 hasLocation W42103281261 @default.
• W4210328126 hasLocation W42103281262 @default.
• W4210328126 hasLocation W42103281263 @default.
• W4210328126 hasOpenAccess W4210328126 @default.
• W4210328126 hasPrimaryLocation W42103281261 @default.
• W4210328126 hasRelatedWork W1755302047 @default.
• W4210328126 hasRelatedWork W2016226163 @default.
• W4210328126 hasRelatedWork W2100845678 @default.
• W4210328126 hasRelatedWork W2106601348 @default.
• W4210328126 hasRelatedWork W2169569625 @default.
• W4210328126 hasRelatedWork W2405536231 @default.

• next